Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants

Clinical trial NCT07220889 · COMPLETED

Trial details

NCT number: NCT07220889
Sponsor: MDI Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety After Oral Intake

Start date: 2025-11-04
Primary completion: 2025-12-16
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.